Healthcare company-building profile
Blavatnik Fund for Innovation at Yale
Yale University (Yale Ventures)
AcceleratorUniversity acceleratorUniversityActive
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- University accelerator
- Organization
- Yale University (Yale Ventures)
- Organization type
- University
- Location
- New Haven, Connecticut
- Company stage served
- Research or idea stage
- Cohort or participation model
- Annual competitive award cycle with expert review panels and milestone-based tranches
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Non-dilutive translational awards administered by Yale Ventures; amounts not published on the overview page
- Equity or fee model
- No equity
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
Public description
About the program
The Blavatnik Fund for Innovation at Yale is Yale Ventures' flagship translational funding program for life science and biomedical discoveries, awarding milestone-based support to faculty projects with commercial potential. It runs alongside Yale's Faculty Accelerator Funds, which deploy roughly $6.5M annually in translational research support. Yale Ventures reports more than 200 faculty-led spinouts and about $6 billion in venture funding raised by Yale spinouts over seven years.
What the program publicly emphasizes
Focus areas and features
Therapeuticsdiagnosticsmedical devicesbiotechtranslational life sciences
- Category: University accelerator
- Program structure: Annual competitive award cycle with expert review panels and milestone-based tranches
- Published terms: Non-dilutive translational awards administered by Yale Ventures; amounts not published on the overview page
Sources
External source links open in a new tab.